Presentation is loading. Please wait.

Presentation is loading. Please wait.

Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003.

Similar presentations


Presentation on theme: "Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003."— Presentation transcript:

1 Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003

2 2/7/20032 On Corporate Integrity “By complying with all applicable laws and regulations, and by adhering to LabCorp’s standards of business conduct, we earn the trust and respect of our fellow workers, customers, shareholders, government employees, elected officials, suppliers, neighbors, friends, the media, and the general public. Therefore, I believe that a strong commitment to corporate integrity is the key to our future success.” Thomas P. Mac Mahon, President and Chairman of the Board Laboratory Corporation of America

3 2/7/20033 OIG Model Compliance Program Guidance for Clinical Laboratories  Medical Necessity –Requisition Design –Notices to Physicians –Test Utilization Monitoring

4 2/7/20034 OIG Model Compliance Program for Clinical Laboratories (cont.)  Billing –CPT/HCPCS Codes –ICD-9 Diagnostic Codes –Tests Covered by Claims for Reimbursement –Billing of Automated Multichannel Chemistry tests –Billing of Calculations

5 2/7/20035 OIG Model Compliance Program for Clinical Laboratories (cont.)  Standing Orders  Marketing  Physician Profile Pricing

6 2/7/20036 Fraud Alerts  In-office Phlebotomy  Waivers of Co-pays, Coinsurance, and Deductibles  Professional Courtesy  Rental or Lease of Space from Physicians

7 2/7/20037 Standard ABN The Advance Beneficiary Notice (“ABN”) informs Medicare patients that their tests may not be covered by Medicare and that they may be liable for any charges for the test.  Valid ABN’s must contain: –Patient’s name –Reasons why the test might not be covered –A checked box indicating the patient’s intent –Patient’s signature and date

8 2/7/20038 2003 OIG Work Plan  Laboratory Proficiency Testing  Clinical Laboratory Testing Outside Certified Specialties  Part B Claims for Glucose Testing

9 2/7/20039 HIPAA Compliance  Privacy –Use of Protected Health Care Information (“PHI”) –Provider Responsibility  Security –Access to Facilities –Access to Information

10


Download ppt "Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003."

Similar presentations


Ads by Google